Pulmonary hypertension and Hip joint replacement

Summary:

Hip joint replacement is found among people with Pulmonary hypertension, especially for people who are female, 60+ old.

The study analyzes which people have Hip joint replacement with Pulmonary hypertension. It is created by eHealthMe based on reports of 82 people who have Pulmonary hypertension from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pulmonary hypertension?

Pulmonary hypertension (increase in blood pressure in the lung artery) is found to be associated with 1,430 drugs and 1,299 conditions by eHealthMe. Check the latest studies of Pulmonary hypertension.

What is Hip joint replacement?

Hip joint replacement is found to be associated with 857 drugs and 1,062 conditions by eHealthMe. Check the latest studies of Hip joint replacement.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

82 people who have Pulmonary Hypertension and Hip Joint Replacement are studied.

Would you have Hip joint replacement when you have Pulmonary hypertension?

Gender of people who have Pulmonary Hypertension and experienced Hip Joint Replacement *:

female: 89.02 %
male: 10.98 %

Age of people who have Pulmonary Hypertension and experienced Hip Joint Replacement *:

Common co-existing conditions for these people *:

Hepatic Cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue): 4 people, 4.88%
Osteoporosis (bones weak and more likely to break): 3 people, 3.66%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 2.44%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 2.44%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 1.22%
Reflux Oesophagitis (an oesophageal mucosal injury that occurs of gastric contents into the oesophagus): 1 person, 1.22%
Pulmonary Embolism (blockage of the main artery of the lung): 1 person, 1.22%
Portal Hypertension (increase in the blood pressure within a system of veins called the portal venous system): 1 person, 1.22%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 1.22%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 1.22%

Common drugs taken by these people *:

Common symptoms for these people *:

Fall: 18 people, 21.95%
Hip Fracture: 12 people, 14.63%
Hypotension (abnormally low blood pressure): 11 people, 13.41%
Nausea (feeling of having an urge to vomit): 10 people, 12.20%
Dyspnea (difficult or laboured breathing): 10 people, 12.20%
Device Related Infection: 9 people, 10.98%
Feeling Abnormal: 9 people, 10.98%
Joint Pain: 9 people, 10.98%
Influenza Like Illness: 8 people, 9.76%
Diarrhea: 8 people, 9.76%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Hip joint replacement?

- Check whether Hip joint replacement is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Hip joint replacement and Pulmonary hypertension, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.